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Abstract
Flavonoids are potential group of phytochemicals found in normal diets 
capable of mediating improvements in cognition and may reverse age-related 
declines in memory. Aging is associated with alteration of hippocampal synaptic 
plasticity and contribute to decline in cognitive functions. The current studies are 
directed at a greater understanding of how and why the brain modifies synaptic 
strength with dietary-derived phytochemicals (flavonoids) and age-related 
declines in cognitive functions (such as learning and memory). Flavonoids 
modulate neuronal function and thereby influence cognition. In addition, it has 
been suggested that flavonoids may delay the development of Alzheimer’s disease-
like pathology, anxiety, and depression disorders, suggesting a novel therapeutic 
strategy. Emerging evidence suggest that flavonoids are modulators of signaling 
pathways critical for controlling synaptic plasticity in the brain. For example, 
phosphatidylinositol-3 kinase (PI3K)/Akt, mitogen-activated protein kinase, 
protein kinase C, pathways could be involved Ca2+ signaling. Significants ques-
tions such as: (i) How does flavonoids affect plasticity? (ii) What receptors are 
modulating by flavonoids and how are they regulated? (iii) Do flavonoids have a 
neuroprotective effect in aging? are asked.
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1. Introduction
Advances in medicine over the last century have resulted in a considerable 
increase in human life expectancy. Despite this positive outcome, with increase 
in age, comes a decline of metabolic and immune functions with impact on the 
cognitive functions. Although, some decline in cognitive function does occur with 
normal aging, there is also an increased age-associated risk of neurodegenerative 
disorders such as Alzheimer’s disease (AD) [1]. At the same time, it highlights the 
need for a more comprehensive understanding of how different aspects of lifestyle 
such as physical exercise, meditation, musical experience, and diet may influence 
brain disorders in a preventative manner, affecting long-term neural function that 
affects cognitive performance [2]. In relation to the diet, flavonoids have been 
described as promising plant-based bioactives capable of modulating different 
aspects of neuroplasticity, resulting in improvements in memory in both rodents [2] 
and humans [3, 4]. For example, flavonoids have been correlated with their ability 
to modulate the phosphorylation state of intracellular proteins by the activation or 
inhibition of phosphoinositide 3-kinase (PI3K), protein kinase C (PKC), mitogen-
activated protein kinase (MAP), CAMP responsive element binding protein 1 
(CREB-1), growth associated protein 43 (GAP-43), brain-derived neurotrophic fac-
tor (BDNF), or to alter expression of N-methyl d-aspartic acid (NMDA) receptors 
(NMDARs), GABAA receptors (GABAARs), and 5-HT receptors (5-HTRs) [5, 6]. In 
addition, flavonoids can modulate epigenetic modifications [7]. These mechanisms 
are critical for the neuroplasticity and they are also related with inflammatory 
processes in the brain.
The aim of this chapter is to highlight the potential of flavonoid-rich food, 
flavonoid-rich extract, and medicinal plants that act as modulators of neuroplas-
ticity in the central nervous system of mammals. We provide an outline of the 
neuroplasticity and how flavonoids affect this mechanism, and we will also describe 
their interaction in the neuroinflammation mechanism that affects the cognition. 
It will highlight the probable mechanisms that flavonoids promote neuroprotective 
effect in aging.
2. Flavonoids structure and brain bioavailability
Flavonoids are a large group of naturally occurring plant-based compounds that 
are commonly consumed through a diet rich in fruit, vegetables, tea, wine, and soy-
based foods, being of considerable scientific and therapeutic interest. Flavonoids 
are responsible for numerous functions in plants. Among them, we can mention 
protection against ultraviolet rays, against insects, fungi, viruses, and bacteria, 
and the ability to provide the attraction of pollinating animals. In addition to these 
characteristics, many of these compounds also possess important pharmacological 
properties, such as antiviral, antitumor, anti-inflammatory, antioxidant, anti-
inflammatory activity, and neuroprotective actions.
Flavonoids consist of two aromatic carbon rings, benzopyran (A and C rings) and 
benzene (B ring) (Figure 1). Flavonoids can be subdivided into different subclasses 
depending on the carbon of the C ring on which the B ring is attached and the degree 
of unsaturation and oxidation of the C ring on which the B ring is attached and the 
degree of unsaturation and oxidation of C ring. Thus, they may be divided in seven 
subclasses as: (1) flavones (e.g. apigenin, luteolin); (2) flavonols (e.g. kaempferol, 
quercetin); (3) isoflavones (e.g. daidzein, genistein); (4) chalcones (e.g. phloretin, 
chalconaringenin); (5) flavanones (e.g. naringenin, hesperetin); (6) anthocyani-
dins (e.g. delphinidin, cyanidin) and, (7) flavanols [e.g. catechin, epicatechin, 
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epigallocatechin, epigallocatechin gallate (EGCG)] [8]. For further information 
regarding the structure and classes of flavonoids, you can see references Andersen 
and Markhan [8].
Although flavonoids display directly modulate brain function, during absorp-
tion; they are extensive metabolized, resulting in a wide variety of metabolic 
derivatives. Do flavonoids access the brain?
In order to understand whether flavonoids are capable of modulating brain 
function, it is important to understand the bioavailability. Bioavailability is a crucial 
factor determining their biological activity in vivo. Therefore, information on the 
absorption and metabolism of dietary flavonoids in the digestive tract is important 
for determining their physiological functions, and what if flavonoids and their 
metabolic derivatives cross the Blood-Brain Barrier (BBB) [9–11]. This point is still 
a matter of debate, despite a number of studies shows the presence of flavonoids 
and their metabolites in brain tissue following oral administration of flavonol, e.g. 
(−) epicatechin [10], flavanones, e.g. hesperetin [11] and flavone, e. g. baicalein 
[12, 13]. The capacity of flavonoids and their metabolites to cross BBB is dependent 
on the degree of lipophilicity of each compound, i.e., less polar O-methylated 
metabolites may be capable of greater brain uptake than the more polar flavonoid 
glucuronides [14].
Bioavailability studies using flavonoids labeled with radioactive were found 
in various brain tissues such as hypothalamus, superior colliculus, cerebellum, 
striatum, and in limbic system structures as cortex and hippocampus [9, 11, 15], 
both important for memory formation, and are also adversely affected by aging 
and neurodegenerative diseases. It is a necessary work to discuss bioavailability of 
flavonoids in brain; however, some studies showed the direct and protective effects 
of flavonoids in modulating brain function, which will be discussed below.
Figure 1. 
Basic skeleton structure of flavonoids, subclasses, and their natural sources.
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3. Impact of flavonoids on cognition
The common medicine has focused on symptoms and treatment but the major-
ity of chronical diseases are the result of unhealthy habits. The lifestyle medicine 
has focused on prevention, which means an increase in life quality, well-being, 
and avoids morbidity conditions [16]. Habitual consumption of dietary flavonoids 
has been consistently linked with improving cognitive functions [17–19]. For this 
reason, the flavonoids have been described as a class promised to maintain cogni-
tion functions and/or to delay in the progression of age-related cognitive. Despite 
a growing body of animal studies demonstrating positive effects in learning and 
memory after flavonoid intake (discussed in the next session), the human clinical 
trials are somewhat scarcer.
The neurobehavioral effects of phytoestrogens have been the limited data that 
exist regarding the influence of soy-derived dietary isoflavones on brain structure 
and function [20]. Clinical trial studies showed the efficacy of isoflavones on cogni-
tive function in postmenopausal women. For example, Long term soy-isoflavone-
based supplement (110 mg/d) for 6 months showed better verbal memory than 
the placebo control group [21]. Similarly, in women aged 50–65 found that intake 
of 60 mg/d for 3 months resulted in cognitive improvement in several categories 
related to frontal cortical functions [22]. Another study, involving younger post-
menopausal women receiving 160 mg/d isoflavones for 6 months, and results 
showed an improvement cognitive flexibility [23].
With respect to anthocyanins, blueberry flavonoids supplement (579 mg/d) 
for 7 days induce cognitive improvements in young and aged adults [24]. Similar 
results were found after 3 months (long-term supplementation) with blueberry 
juice in older adults with cognitive impairment in working memory [25]. Some 
studies address the cognitive impact of a single dose of a blueberry juice in children 
(8–10 years old) [26]. This study showed for the first time a cognitive benefit for 
acute flavonoid intervention in children. Another study with 30 g of lyophilized 
anthocyanins, equivalent to 240 g or 1½ cups of fresh blueberries, demonstrated 
beneficial cognitive effects on memory and attention, not extending reading ability, 
in healthy children of 7–10 years of age. These findings increase the growing body 
of evidence that flavonoids are beneficial to healthy brain function [27].
Finally, precise estimation of nutrient intake is essential for establishing a 
relationship between diet and cognitive function. However, estimations of dietary 
flavonoid intake need to take into account their complexity and variability. More 
recently, a review reported wide range for mean total flavonoid intakes between 209 
and 1017 mg/d (mean 435 mg/d) in European, US, and Australian adult populations 
[28]. In Brazil, the estimate is between 60 and 106 mg/d [29]. There are substantial 
variations in population estimates of dietary flavonoid intake, which may be associ-
ated to true differences in dietary patterns, such as differences in the food supply 
and cultural eating patterns between countries. Further studies are required to 
address and to detect effects of dietary interventions on human cognitive functions.
4.  Mechanisms underpinning the actions of flavonoids as synaptic 
plasticity modulators
Flavonoid subclass has been extensively studied. For this reason, flavonoids 
have been recognized as promising agents capable of influencing different aspects 
of synaptic plasticity resulting in improvements in learning and memory. It is 
not completely clear how flavonoids affect synaptic plasticity. A growing body of 
evidence suggests that they can (1) modulate receptor function, and (2) promote 
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the expression of synaptic plasticity-related genes and proteins (Figure 2). The next 
sections outline the effects of flavonoids in synaptic plasticity and how these may 
underpin improvements in memory.
4.1 Flavonoid-receptor interactions
There are a number of studies that support the flavonoid-receptor interactions. 
For example, blueberry intake by young rodents increases the levels of GluN2b 
subunit of N-methy-d-aspartate receptor (NMDAR) in hippocampus [30]. 
Similarly, in young rodents, acute effect of oral flavonoid-rich fraction (Ff) intake 
up-regulated mRNA expression of the GluN2b subunit in dorsal hippocampus 
[5]. The flavonoid-rich fraction (Ff) containing flavones (Vitexin, Isovitexin, and 
6-C-glycoside-Diosmetin) and improves learning and memory in young rodents. 
It is known that NMDARs are centrally involved in synaptic transmission, synap-
tic plasticity (long-term potentiation – LTP and long-term depression – LTD), and 
learning and memory [31]. According to this, quercetin resulted in improvements 
of hippocampal CA1 long-term potentiation in acute hippocampal slice from 
young rats [32].
The serotoninergic and GABAergic neurotransmissions are involved in learning 
and memory; the major targets are 5-HT1ARs and GABAARs, and the modula-
tion of these receptors in the hippocampus is essential for the acquisition and 
consolidation of memory [33–35]. Supporting, acute effect of oral Ff up-regulated 
mRNA expression of the 5-HT1AR and GABA(A) alpha 5 receptor in dorsal hip-
pocampus from young rats [5]. Molecular docking study showed that flavones 
such as Isovitexin and 6-C-glycoside-Diosmetin exhibited a strong interaction 
with the GABAA BZ binding pocket. Those flavones showed a lack of interaction 
with α1His101, which may explain the memory-enhancing effect identified in the 
behavioral test in young rats [36].
Flavonoids can modulate other receptors such as TrKB [37], δ-opioid [38, 39], 
nicotinic [40, 41], estrogen [42, 43], and adenosine [44–46]. For example, 7,8-dihy-
droxyflavone, a flavone, was shown high-affinity agonist of the TrKB receptor [47]. 
In addition, the flavones may improve cognition by modulating the acetylcholine 
and neurotrophic factors synthesis in hippocampus and frontal cortex [27, 48]. 
Those flavonoid-binding sites show many possibilities of flavonoids action mecha-
nisms to modulate cognition and brain physiology.
4.2 Flavonoid-signaling pathways interactions
Receptor binding by flavonoids is responsible by changes in the up-regulated 
and down-regulated pathways such as, PI3K, PKC, MAP kinases, and nuclear 
factor-κB pathway. Their influence on such pathways suggests that they may 
modulate synaptic plasticity involved in neurodegenerative diseases, and memory 
acquisition, consolidation, and storage.
Short-term and long-term treatment of oral Ginkgo biloba (EGb) extract up-
regulated mRNA and protein of the CREB-1 and GAP-43 in dorsal hippocampus 
Figure 2. 
Mechanisms underpinning the actions of flavonoids.
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from young rats [49, 50]. These molecules are associated with molecular mechanism 
LTP, and it has been shown that the transcription factor, cAMP response element-
binding protein (CREB), may regulate the synthesis of new proteins necessary 
for the formation of memory. Another potential protein associated with LTP is 
the protein 43-kDa growth-associated protein (GAP-43), and they dramatically 
enhances during LTP [51–53]. Quercetin-increased expression of activity-regulated 
cytoskeletal-associated protein (Arc/Arg3.1) [54] pathway is important for memory.
Flavanols and flavanones activate the ERK pathway [55–58] and ERK modulate 
cAMP response element binding protein (CREB) activation, which is involved in 
long-term changes in synapses and memory formation [37–39]. Similarly, acute 
effect of oral Ff up-regulated mRNA expression of the ERK in dorsal hippocampus 
from young rats [5].
In addition, the flavonoids may modulate the protein kinases, as MAP-kinase 
and PI3-kinase [59–62], the alteration on activation of kinase may influence directly 
on modulation of activity-dependent plasticity and morphological changes in 
synapses involved in memory acquisition, consolidation, and storage [63].
In summary, the ability of flavonoids to influence receptor activity and synaptic 
plasticity suggest that these might underpin enhancements in cognitive func-
tions in both health conditions and neurological/psychiatric disorders. Additional 
approaches are required to understand the molecular mechanisms involved in these 
processes, for example, electrophysiological studies in rodents and human.
5. Prevention of cognitive decline through lifestyle interventions
There is increasing evidence that diet rich in flavonoid or supplements might 
delay the initiation of and/or slow the progression of cognitive decline related to 
aging and Alzheimer’s diseases (AD). Among existing dietary patterns, adher-
ence to a Mediterranean diet is associated with less cognitive decline, dementia, 
or AD [64, 65]. For example, a meta-analysis showed that greater adherence to a 
Mediterranean-style dietary pattern during older adulthood was associated with a 
lower risk of developing several different health outcomes such as CVD, neurode-
generative disorders, cancer, and overall mortality [66].
With regard to AD, the consumption of food rich in flavonoids such as red wine, 
fruit juice, and vegetables has been shown to delay the onset of AD [17, 67]. This 
is in accordance with previous studies linking high consumption of flavonoids to 
decline related to aging and dementia [19, 68]. A number of studies using animal 
models of AD have begun to investigate the possible mechanisms involved in these 
effects. For example, oral administration of the green tea flavonoid EGCG for 
6 months to mice overexpressing the Swedish mutation of APP (Tg2576) reduced 
amyloid β (Aβ) pathology as well as improving cognition [69], and similarly long-
term green tea catechin administration improved spatial learning and memory in 
senescence-prone mice [70]. Furthermore, feeding APP+PS1 double-transgenic 
mice blueberry from 4 months of age prevented deficits in Y-maze performance at 
12 months, without altering the Aβ burden [71]. The myricetin and morin are suc-
cessful to inhibit the β-sheet of Aβ oligomers. Apigenin, a flavone, and quercetin, a 
flavonol, have shown promising results with animal model of AD, and quercetin has 
shown to be benefit to early-stage AD patients [72].
The mechanism underlying these changes is not clear but might be linked to 
increase α-secretase activity [73] reported in vitro and in vivo after i.p. injection of 
EGCG [42, 74] or due to disruption of cAbl/Fe65 interactions [75]. Gallic acid and 
catechin-rich grape seed polyphenolic extract (GSPE) administered for 5 months 
to Tg2576 mice inhibited cognitive deterioration coincident with reduced levels of 
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soluble high-molecular-weight oligomers of Aβ [76]. Moreover, GSPE also inhibits 
tau fibrillization, promotes the loss of preformed tau aggregates, and disrupts 
paired helical filaments [77–80]. EGCG seems to have broadly similar effects. 
(−)-Epicatechin and hesperetin hold the potential to inhibit the development of tau 
pathology through an alternative mechanism relating to their ability to enhance Akt 
phosphorylation, thereby inhibiting GSK3β-induced tau hyperphosphorylation 
[55, 56]. Overall, this supports the claim that orally active flavonoids could have the 
utility in AD beyond anti-Aβ actions. The challenge ahead is to determine if flavo-
noids have efficacy in individuals affected by dementia.
6. Discussion: future directions
The consumption of flavonoid-rich foods and supplements throughout life 
may have the potential to limit or even reverse the progression of cognitive decline 
related of aging and potentially delay the onset and progression of dementia. The 
mechanisms by which flavonoids modulate cognitive functions are yet to be fully 
established.
In relation to synaptic plasticity, it will be particularly important to investigate 
the potential effect of flavonoids that mediate the induction of long-term depres-
sion (LTD), short-term potentiation (STP), and long-term potentiation (LTP) in 
hippocampus area. To dementia, it will be important to investigate the potential 
utility of flavonoids in the modulation of amyloid β pathology in more detail. In 
addition, it will be important to clearer dietary recommendations on flavonoid 
intake (including potentially a “recommended daily intake” level). Indeed, there are 
a number of important questions still to be resolved.
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